2m 2m 2m 2m 2m 2m 2m
Gilead Sciences (GILD)
NASDAQ
$131.06+$1.22 (+0.94%)
Price as of Jul 13, 2026 7:15 PM EDT- $161.2BMarket Cap
- 21.50%1-Year Change
- Drug Manufacturers - GeneralIndustry
Gilead Sciences (GILD)
$131.06+$1.22 (+0.94%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD GROUP INC | 9.75% | 121.1M | +2.1M (+1.75%) | Dec 31, 2025 |
BLACKROCK INC. | 9.72% | 120.6M | -1.9M (-1.57%) | Jun 30, 2024 |
BLACKROCK FUNDING, INC. /DE | 9.69% | 120.4M | -1.6M (-1.31%) | Dec 31, 2024 |
BLACKROCK, INC. | 9.59% | 119.0M | -4.2M (-3.52%) | Mar 31, 2026 |
FMR LLC | 5.79% | 71.9M | +6.3M (+8.80%) | Mar 31, 2026 |
STATE STREET CORP | 4.82% | 59.9M | -381,933 (-0.64%) | Mar 31, 2026 |
CAPITAL WORLD INVESTORS | 3.33% | 41.3M | -1.6M (-3.85%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 6.76% | 83.9M | +732,133 (+0.87%) | Mar 31, 2026 |
PIMCO FUNDS | 4.56% | 56.7M | 0 (0.00%) | Mar 31, 2026 |
JPMorgan Trust I | 3.42% | 42.5M | 0 (0.00%) | Apr 30, 2026 |
MORGAN STANLEY INSTITUTIONAL FUND TRUST | 3.22% | 40.0M | 0 (0.00%) | Mar 31, 2026 |
J.P. Morgan Exchange-Traded Fund Trust | 2.37% | 29.4M | 0 (0.00%) | Apr 30, 2026 |
VANGUARD WELLESLEY INCOME FUND | 2.36% | 29.3M | 0 (0.00%) | Mar 31, 2026 |
JOHN HANCOCK SOVEREIGN BOND FUND | 2.22% | 27.6M | 0 (0.00%) | Feb 28, 2026 |
Current Ownership Distribution
- Institutions18.6B (64.31%)
- Mutual Funds10.3B (35.63%)
- Insiders15.4M (0.05%)
- Other0 (0.00%)
Insider Transactions
- 0.05% (15.4M)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $19.6MAmount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $1.7BAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
O'Day Daniel Patrick Chairman & CEO | Sell | Jul 01, 2026 | $1.5M | 11,900 | $126.09 | 610,233 |
O'Day Daniel Patrick Chairman & CEO | Sell | Jul 01, 2026 | $393,932.50 | 3,100 | $127.08 | 607,133 |
Dickinson Andrew D Chief Financial Officer | Sell | Jun 15, 2026 | $376,200.00 | 3,000 | $125.40 | 171,646 |
Mercier Johanna Chief Comm & Corp Aff Officer | Sell | Jun 15, 2026 | $182,656.57 | 1,480 | $123.42 | 125,754 |
Mercier Johanna Chief Comm & Corp Aff Officer | Sell | Jun 15, 2026 | $132,675.51 | 1,070 | $124.00 | 124,684 |
Mercier Johanna Chief Comm & Corp Aff Officer | Sell | Jun 15, 2026 | $56,430.00 | 450 | $125.40 | 124,234 |
O'Day Daniel Patrick Chairman & CEO | Exempt | Jun 10, 2026 | $0.00 | 8,779 | $0.00 | 92,080 |
Mercier Johanna Chief Comm & Corp Aff Officer | Exempt | Jun 10, 2026 | $0.00 | 2,796 | $0.00 | 27,851 |
Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | Exempt | Jun 10, 2026 | $0.00 | 589 | $0.00 | 19,997 |
Berger Dietmar Chief Medical Officer | Exempt | Jun 10, 2026 | $0.00 | 533 | $0.00 | 46,928 |
O'Day Daniel Patrick Chairman & CEO | Exempt | Jun 10, 2026 | $0.00 | 8,779 | $0.00 | 626,346 |
Mercier Johanna Chief Comm & Corp Aff Officer | Exempt | Jun 10, 2026 | $0.00 | 2,796 | $0.00 | 128,575 |
Dickinson Andrew D Chief Financial Officer | Exempt | Jun 10, 2026 | $0.00 | 2,796 | $0.00 | 27,851 |
Berger Dietmar Chief Medical Officer | Exempt | Jun 10, 2026 | $0.00 | 533 | $0.00 | 19,515 |
O'Day Daniel Patrick Chairman & CEO | In Kind | Jun 10, 2026 | $511,795.24 | 4,213 | $121.48 | 622,133 |
Mercier Johanna Chief Comm & Corp Aff Officer | In Kind | Jun 10, 2026 | $162,904.68 | 1,341 | $121.48 | 127,234 |
Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | Exempt | Jun 10, 2026 | $0.00 | 589 | $0.00 | 5,643 |
Berger Dietmar Chief Medical Officer | In Kind | Jun 10, 2026 | $31,949.24 | 263 | $121.48 | 19,252 |
Dickinson Andrew D Chief Financial Officer | Exempt | Jun 10, 2026 | $0.00 | 2,796 | $0.00 | 175,987 |
Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | In Kind | Jun 10, 2026 | $34,378.84 | 283 | $121.48 | 5,360 |
Dickinson Andrew D Chief Financial Officer | In Kind | Jun 10, 2026 | $162,904.68 | 1,341 | $121.48 | 174,646 |
O'Day Daniel Patrick Chairman & CEO | Sell | Mar 27, 2026 | $1.4M | 10,000 | $136.82 | 642,567 |
Mercier Johanna Chief Comm & Corp Aff Officer | Sell | Mar 16, 2026 | $432,690.00 | 3,000 | $144.23 | 131,779 |
Dickinson Andrew D Chief Financial Officer | Sell | Mar 16, 2026 | $432,690.00 | 3,000 | $144.23 | 179,191 |
Burkhart Erin SVP, Controllership | Award | Mar 10, 2026 | $0.00 | 2,355 | $0.00 | 11,245 |
O'Day Daniel Patrick Chairman & CEO | Exempt | Mar 10, 2026 | $0.00 | 20,026 | $0.00 | 68,044 |
Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | Exempt | Mar 10, 2026 | $0.00 | 1,246 | $0.00 | 15,536 |
Dickinson Andrew D Chief Financial Officer | Exempt | Mar 10, 2026 | $0.00 | 6,469 | $0.00 | 21,057 |
Burkhart Erin SVP, Controllership | Award | Mar 10, 2026 | $0.00 | 5,455 | $0.00 | 5,455 |
Berger Dietmar Chief Medical Officer | Exempt | Mar 10, 2026 | $0.00 | 2,133 | $0.00 | 39,046 |